Skip links
Pharmaceutical tariffs, trade flows and emerging economies

Pharmaceutical tariffs, trade flows and emerging economies

By Philip Stevens and Nilanjan Banik
Published on:
Pharmaceutical tariffs, trade flows and emerging economies

 

Nilanjan Banik and Philip Stevens

September 2015

Pharmaceutical tariffs could be a barrier to access to medicines. This Working Paper looks at current levels of vaccine and pharmaceutical tariffs worldwide, and examines trade flows amongst the biggest exporting and importing nations.

Among the main findings: The vast majority of high-income countries do not levy pharmaceutical tariffs. A number of countries maintain tariffs on medicaments of over 8 per cent. These include Russian Federation (10.2%), India (10%), Uruguay (9.9%), Argentina (9.8%), Brazil (9.8%) and Thailand (9.3%).

 

Download PDF

Leave a comment

Philip Stevens
Executive Director

Philip Stevens in the Founder and Executive Director of Geneva Network. He is also a Senior Fellow at the Institute for Democracy and Economic Affairs, Malaysia.

Nilanjan Banik
Senior Fellow

Nilanjan Banik is a Professor at Bennett University’s School of Business, India and a Senior Fellow at Geneva Network.